Understanding HPV and cervical screening

Butler, Sarah; Wilkinson, Yvonne

Abstract

Cervical cancer is preventable and curable. Sarah Butler and Yvonne Wilkinson explain how the cervical screening programme has changed from a cytology based test to HPV primary screening

Screening for human papillomavirus is now the primary test for cervical screening in England, Wales and Scotland. Cervical screening for those individuals with a cervix routinely occurs every 3 years for those aged 25–49 (24½ in England) and every 5 years for those aged 50–64. Over 99.7% of cervical cancers are caused by human papillomavirus. Cervical cancer is preventable and curable; primary HPV screening can detect early changes in cervical cells allowing for effective monitoring and treatment.

Citation

Butler, S., & Wilkinson, Y. (2022). Understanding HPV and cervical screening. Practice Nursing, 33(1), 14-17. https://doi.org/10.12968/pnur.2022.33.1.14

• Journal Article Type: Article
• Acceptance Date: Nov 30, 2021
• Online Publication Date: Dec 30, 2021
• Publication Date: Jan 2, 2022
• Deposit Date: Jan 12, 2022
• Publicly Available Date: Oct 27, 2022
• Journal: Practice Nursing
• Print ISSN: 0964-9271
• Electronic ISSN: 2052-2940
• Publisher: MA Healthcare
• Peer Reviewed: Peer Reviewed
• Volume: 33
• Issue: 1
• Pages: 14-17
• DOI: https://doi.org/10.12968/pnur.2022.33.1.14
• Keywords: Cervical cancer; Human papillomavirus infections; Public health; Vaccination
• Public URL: https://hull-repository.worktribe.com/output/3910444